Gurnee, IL, United States of America

Frank L Wagenaar

This inventor holds 2 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank L Wagenaar. Retrieved from https://idiyas.com/inventor/frank-l-wagenaar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 31.9

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Frank L. Wagenaar: Innovator in Neuraminidase Research

Introduction

Frank L. Wagenaar is a notable inventor based in Gurnee, Illinois, recognized for his contributions to the field of biochemistry and pharmaceuticals. With two patents to his name, he has made significant advancements, particularly in the area of neuraminidase inhibitors.

Latest Patents

Wagenaar's latest patents include groundbreaking work on inhibitors of neuraminidases. These patents represent important strides in developing therapeutic agents that can combat viral infections, specifically those caused by influenza viruses.

Career Highlights

Frank L. Wagenaar is affiliated with Abbott Laboratories Corporation, a global healthcare company. His career highlights not only showcase his patent achievements but also underline his dedication to improving health outcomes through scientific research and innovation.

Collaborations

Throughout his tenure at Abbott Laboratories, Wagenaar has collaborated with notable colleagues, including Clarence J. Maring and Yu Gui Gu. Their joint efforts have played a crucial role in progressing research initiatives aimed at understanding and inhibiting viral enzymes.

Conclusion

In conclusion, Frank L. Wagenaar is a prominent figure in the realm of inventions focused on healthcare. His patents on neuraminidase inhibitors are pivotal contributions to medical research, demonstrating his commitment to innovation and collaboration in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…